J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on February 1, 2005

Papers In Press, published online ahead of print December 1, 2004
J. Lipid Res., doi:10.1194/jlr.M400256-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M400256-JLR200v1
46/2/287    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Honda, A.
Right arrow Articles by Shefer, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Honda, A.
Right arrow Articles by Shefer, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on July 6, 2004
Revised on November 16, 2004
Accepted on November 18, 2004

Disrupted coordinate regulation of farnesoid X receptor (FXR) target genes in a patient with cerebrotendinous xanthomatosis

Akira Honda, Gerald Salen, Yasushi Matsuzaki, Ashok K. Batta, Guorong Xu, Takeshi Hirayama, G. Stephen Tint, Mikio Doy, and Sarah Shefer

Ibaraki Prefectural Institute of Public Health, Mito, Ibaraki 310-0852

Corresponding Author: AkiraHonda{at}aol.com

Farnesoid X receptor (FXR) is a pivotal nuclear transcription factor that regulates bile acid biosynthesis and transport. Since cerebrotendinous xanthomatosis (CTX), CYP27A1 deficiency, is associated with markedly reduced chenodeoxycholic acid (CDCA) pool and CDCA is believed to be the most powerful activating ligand for FXR, we investigated the effects of reduced CDCA on FXR target genes in humans. Liver specimens from an untreated and a CDCA treated CTX patients and ten control humans were studied. Hepatic enzyme activities and concentrations of oxysterols, bile acids, and bile alcohols were measured by high-resolution GC-SIM. Hepatic mRNA levels were determined by real-time quantitative PCR assay. In the untreated CTX patient, hepatic CDCA concentration was markedly reduced but the bile alcohol level (73.5 nmol/g liver) exceeded CDCA levels in control subjects (37.8  6.2 nmol/g liver). CYP7A1 and Na+/taurocholate cotransporting polypeptide (NTCP) which are positively controlled by deactivated FXR were up-regulated 84- and 8-fold, respectively. However, small heterodimer partner (SHP) and bile salt export pump (BSEP) that are negatively controlled by deactivated FXR were normally expressed. To explore the mechanism of dissociating marked CYP7A1 induction from normal SHP expression, we evaluated the status of other nuclear receptors, liver X receptor alpha (LXRalpha ) and pregnane X receptor (PXR), which may regulate CYP7A1 expression independent of SHP. However, activation of LXRalpha or PXR pathway was not influenced by CYP27A1 deficiency. In contrast, another nuclear receptor, hepatocyte nuclear factor 4alpha (HNF4alpha ), was induced 2.9-fold in CTX, which was associated with enhanced mRNA levels of HNF4alpha target genes, CYP7A1, CYP8B1, CYP27A1 and NTCP. In conclusion, the coordinate regulation of FXR target genes was lost in CTX. The mechanism of the disruption may be explained by normally stimulated FXR pathway due to markedly increased bile alcohols with activation of HNF4alpha due to reduced bile acids in CTX liver.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.